Pharmacological interventions part III
Authors:
- Tomas KoltaiTKTomas Koltai
- Stephan J. ReshkinSRStephan J. Reshkin
- Salvador HarguindeySHSalvador Harguindey
- 1 January 2020
- book chapter
- Published by Elsevier
- p. 335-359
Abstract
No abstract availableKeywords
This publication has 150 references indexed in Scilit:
- Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) SignalingJournal of Biological Chemistry, 2012
- Salinomycin induces calpain and cytochrome c-mediated neuronal cell deathCell Death & Disease, 2011
- Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiationRadiotherapy and Oncology, 2011
- Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 proteinBritish Journal of Pharmacology, 2010
- Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growthThe Prostate, 2010
- Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvateBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI: Journal of the National Cancer Institute, 2008
- Statins and cancer preventionNature Reviews Cancer, 2005